Motilal Oswal BSE Healthcare ETF
Motilal Oswal Mutual Fund · scheme code 150445 · ISIN INF247L01BB1
Scheme
| Latest NAV | ₹52.3744 |
|---|---|
| NAV date | 28 Aug 2026 |
| Category | Other · Other ETF |
| Structure | Open Ended |
| Status | Open — priced in AMFI's latest file |
| As published by AMFI | Open Ended Schemes(Other Scheme - Other ETFs)
StockProof normalizes AMFI's 104 category spellings onto 56 categories; this is the raw string behind the one shown above. |
| Stored NAV history | 740 points, 01 Sep 2023 → 28 Aug 2026 |
Data, not advice. These pages show NAV history, category and computed returns as published by AMFI, so funds can be compared side by side. StockProof does not rank funds, does not score them, and does not recommend buying, selling or holding any of them. Past NAV movement is not an indication of future returns.
Fund names here are CURRENT names, not the name the fund had on the date shown. AMFI retroactively restates historical scheme names to whatever the fund is called today: its own April 2006 file lists schemes under "Nippon India Mutual Fund", a fund house that did not exist until 2019 (it was Reliance). Measured on 2026-08-29, all 1,947 scheme codes present in both AMFI's 2018 and 2026 files showed zero name changes — not because renames are rare in the Indian fund industry, but because the history is rewritten. StockProof stores and shows only the current name and does not attempt to reconstruct point-in-time names, because AMFI publishes nothing that would make that possible. The NAV figures themselves are as published for each date and are not restated.
Long-window returns are measured only over funds that still exist. Of the 1,790 scheme codes AMFI priced in April 2006, only 568 (31%) were still being priced in 2026. Funds that closed or merged are not in a long-period comparison, so any group of surviving funds looks better than the choice an investor actually faced at the time.
Exchange listing
This scheme is an exchange-traded fund: unlike an ordinary mutual fund it is bought and sold on the exchange at whatever price the market sets, so it has a traded price as well as a NAV.
| NSE symbol | MOHEALTH |
|---|---|
| Tracks | MotilalOswalS&PBSEHealthcareETF |
| Listed on NSE | 04 Aug 2022 |
| Market lot | 1 |
| Face value | ₹10.00 |
| How the symbol was matched | Matched to an NSE symbol by ISIN
on ISIN INF247L01BB1, the only identifier AMFI and NSE both publish |
Premium and discount are a measurement, not a verdict. An ETF has two prices on the same day: the NAV its fund house declares, and the price it actually traded at on NSE. This page shows the gap between them, computed as (traded close − NAV) ÷ NAV. A premium does not mean the fund is expensive and a discount does not mean it is cheap — persistent gaps usually reflect how and when the NAV itself is struck, not a mispricing anyone can act on. StockProof does not rank ETFs, score them, or recommend buying, selling or holding any of them.
Every figure here pairs a traded price with the NAV for THE SAME DATE, and days where only one of the two exists are excluded rather than filled in. That is why the paired-day count below can be lower than either the price history or the NAV history on its own. Comparing one day's price against another day's NAV would report that day's market movement as a premium — on a day the market moved 1.5%, it would invent a 1.5% premium that never existed.
A wide, persistent gap is usually about NAV timing rather than the market. An ETF holding overseas assets has its NAV struck from a foreign close that happens after Indian trading ends, so its traded price reflects newer information than the NAV it is compared against here. A debt ETF's NAV is struck on valuation-agency matrix prices that no one necessarily transacted at. Gold and silver ETF NAVs follow a domestic reference rate. In each case the two numbers are measured differently, and the difference between them is not evidence that either one is wrong.
A closing price is only as meaningful as the trading behind it. Many Indian ETFs trade in very small volumes, where the day's close can be a single small trade rather than a price the market cleared at, and a large premium on a nearly untraded day is mostly noise. Traded quantity is shown beside every figure so a gap measured on thin volume is visibly not the same fact as one measured on heavy volume. On a day an ETF did not trade at all, no premium is computed.
Market prices here are NSE's own end-of-day bhavcopy closes, never restated for corporate actions — unlike the price history on StockProof's company pages, which is adjusted. That is deliberate: AMFI never restates a published NAV either, so comparing an adjusted price against an unadjusted NAV would show a growing artificial discount on every ETF that has ever made a payout.
Premium / discount to NAV
Computed as (traded close − NAV) ÷ NAV, on the 737 days where both a traded price and a NAV exist for the same date — out of 742 days of stored prices and 740 days of stored NAV.
| Latest (28 Aug 2026) | +0.14% above NAV — within 0.5% of NAV |
|---|---|
| traded close | ₹52.45 |
| NAV that day | ₹52.3744 |
| units traded | 47802 |
| Mean over the paired days | +0.108% |
| Median | +0.123% |
| Range | -2.45% to +4.38% |
| Days above / below NAV | 489 above, 248 below |
| Furthest from NAV | +4.38% on 07 Apr 2025
₹41.39 against a NAV of ₹39.6525, on 89239 units traded |
Over time
Zero is the NAV. A point above the line means the ETF traded above its NAV that day, below means under. Days with no trade, or no NAV, are absent rather than interpolated.
Most recent paired days
| Date | Traded close | NAV | Premium / discount | Units traded |
|---|---|---|---|---|
| 28 Aug 2026 | ₹52.45 | ₹52.3744 | +0.144% above | 47802 |
| 27 Aug 2026 | ₹51.83 | ₹52.0865 | -0.492% below | 118365 |
| 26 Aug 2026 | ₹52.14 | ₹51.8847 | +0.492% above | 42093 |
| 25 Aug 2026 | ₹51.56 | ₹51.6704 | -0.214% below | 55544 |
| 24 Aug 2026 | ₹51.24 | ₹51.3386 | -0.192% below | 46919 |
| 21 Aug 2026 | ₹51.40 | ₹51.3106 | +0.174% above | 39161 |
| 20 Aug 2026 | ₹51.56 | ₹51.4813 | +0.153% above | 17510 |
| 19 Aug 2026 | ₹51.25 | ₹51.3569 | -0.208% below | 27562 |
| 18 Aug 2026 | ₹51.46 | ₹51.5823 | -0.237% below | 34988 |
| 17 Aug 2026 | ₹51.41 | ₹51.4564 | -0.090% below | 26366 |
| 14 Aug 2026 | ₹51.76 | ₹51.7475 | +0.024% above | 38464 |
| 13 Aug 2026 | ₹51.79 | ₹51.8033 | -0.026% below | 29296 |
| 12 Aug 2026 | ₹51.78 | ₹51.7314 | +0.094% above | 72614 |
| 11 Aug 2026 | ₹52.31 | ₹52.1375 | +0.331% above | 40588 |
| 10 Aug 2026 | ₹52.02 | ₹51.9555 | +0.124% above | 47762 |
| 07 Aug 2026 | ₹52.10 | ₹52.0027 | +0.187% above | 24695 |
| 06 Aug 2026 | ₹51.90 | ₹51.7425 | +0.304% above | 43542 |
| 05 Aug 2026 | ₹51.57 | ₹51.7223 | -0.294% below | 70605 |
| 04 Aug 2026 | ₹51.71 | ₹51.5423 | +0.325% above | 46392 |
| 03 Aug 2026 | ₹51.52 | ₹51.5075 | +0.024% above | 97623 |
Benchmark & AUM
Benchmark, benchmark return and AUM figures on this page are AMFI's own published disclosure — the same SEBI-mandated benchmark every fund must declare and report against, sourced from AMFI's Fund Performance data. StockProof does not compute the benchmark return itself: it shows the number AMFI and the fund house publish, exactly as published. StockProof does not rank funds or benchmarks by this figure, and this is not a recommendation to buy, sell or hold anything.
This section is matched to the scheme above by FUND NAME, not by scheme code or ISIN — AMFI's benchmark-disclosure API carries neither, unlike its NAV files. Measured 2026-08-29 across the whole universe, this name match succeeds for about 86% of funds; most misses are small spelling or punctuation drift between AMFI's own two systems, not a wrong match — a fund with no match here simply shows no data rather than another fund's. One disclosed row also covers BOTH the Regular and Direct plan of a fund together, because that is the granularity AMFI itself publishes at — one level coarser than the per-plan scheme codes StockProof otherwise tracks.
| Benchmark | BSE Healthcare TRI |
|---|---|
| Daily AUM | ₹0.45 Bn |
| As of | 27 Aug 2026 |
| Riskometer — scheme | Very High |
| Riskometer — benchmark | Very High |
Fund vs benchmark
Regular and Direct are the plan's own trailing return; Benchmark is the same window's return on the declared benchmark above, as published by AMFI. A window is blank when AMFI has not published it for this fund, most often because the fund has not existed that long.
| Window | Regular | Direct | Benchmark |
|---|---|---|---|
| 1 Year | 16.73% | — | 16.96% |
| 3 Year | 23.17% | — | 23.49% |
| 5 Year | — | — | — |
| 10 Year | — | — | — |
| Since launch | 22.30% | — | see below |
"Since launch" benchmark return is shown per plan, not as one column above — the Regular and Direct plan of a fund can launch on different dates, so each is benchmarked over its own window: Regular 22.63%, Direct —.
Holdings X-ray
These holdings are the fund house's own SEBI-mandated monthly portfolio disclosure, read from the file the AMC publishes and shown as published. StockProof does not estimate, model or infer a single holding. The portfolio is a SNAPSHOT on the date shown — usually a month-end — and a fund can and does trade in between, so what it holds today is not necessarily what is listed here. Nothing on this page ranks funds, scores them, or recommends buying, selling or holding anything.
StockProof can only link a holding to a company page if that company is in the Nifty 500 universe it tracks. Everything the fund disclosed is listed here either way — holdings outside that universe are shown with their real names and weights and counted explicitly as "outside tracked universe", never dropped. Two coverage figures are given because they can differ enormously and either one alone is misleading: the share of holding LINES that link, and the share of disclosed WEIGHT that links. Parag Parikh Flexi Cap Fund is the standing example — under half its lines link, but around three-quarters of its weight does, because its unlinked positions are a handful of very large US holdings.
Coverage varies enormously by fund type and low coverage is a fact about the universe boundary, not a defect. Large-cap, flexi-cap and index funds typically X-ray at over 90% of disclosed weight; small-cap funds fall to roughly 44–75%, because much of what they own sits below the Nifty 500; and a pure debt fund links at zero, because bonds are not companies in StockProof's universe at all. Read the coverage figure before reading the holdings: at 45% coverage the listed companies are a minority of the fund.
The disclosed holdings usually do not add to 100% of the fund. The remainder is cash, TREPS, repo and derivative margin, which the AMC reports without a security line. Weights here are the AMC's own "% to NAV" figures, so they are shares of the WHOLE fund and can be added up directly — but the total falling short of 100% is normal and is shown rather than scaled away.
Holdings are matched to companies by ISIN — the security's own permanent identifier, never by name — so a matched company is the security the fund disclosed and not a guess. The FUND itself is matched to this page by NAME, which is weaker: measured 2026-08-30 across 625 portfolios, that name match succeeds for about 91% of funds, because the AMC's file carries no AMFI scheme code. A fund with no match simply shows no holdings section rather than another fund's. One disclosed portfolio also covers every plan and option of a fund at once, since that is the granularity the fund house publishes at.
How much of this fund StockProof can show
| Of the weight the fund disclosed, tracked | 90.1% | 89.8% of NAV, out of the 99.7% the fund disclosed in security lines |
|---|---|---|
| Of the holding lines disclosed, tracked | 37.6% | 47 of 125 positions. This can differ sharply from the weight figure above — a few very large untracked holdings move one and not the other. |
| Outside StockProof's tracked universe | 78 | 9.9% of NAV — listed in full below with real names and weights, never dropped |
| Not in any security line | 0.3% | cash, TREPS, repo and derivative margin, which the fund house reports without a security line |
Portfolio as disclosed by Motilal OswalBSE Healthcare ETF on 31 Jul 2026, read from the fund house's own published file (sheet YO36). The unit check passed: 99.67% of NAV over 125 lines is consistent with 'percent'.
| Holding | Industry / rating | % of NAV | Tracked |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited INE044A01036 | Pharmaceuticals & Biotechnology | 13.32% | on StockProof |
| Divi's Laboratories Limited INE361B01024 | Pharmaceuticals & Biotechnology | 6.37% | on StockProof |
| Apollo Hospitals Enterprise Limited INE437A01024 | Healthcare Services | 5.67% | on StockProof |
| Cipla Limited INE059A01026 | Pharmaceuticals & Biotechnology | 5.17% | on StockProof |
| Max Healthcare Institute Limited INE027H01010 | Healthcare Services | 5.04% | on StockProof |
| Torrent Pharmaceuticals Limited INE685A01028 | Pharmaceuticals & Biotechnology | 4.52% | on StockProof |
| Dr Reddys Laboratories Limited INE089A01031 | Pharmaceuticals & Biotechnology | 4.34% | on StockProof |
| Laurus Labs Limited INE947Q01028 | Pharmaceuticals & Biotechnology | 4.32% | on StockProof |
| Lupin Limited INE326A01037 | Pharmaceuticals & Biotechnology | 3.63% | on StockProof |
| Fortis Healthcare Limited INE061F01013 | Healthcare Services | 3.05% | on StockProof |
| Aurobindo Pharma Limited INE406A01037 | Pharmaceuticals & Biotechnology | 2.73% | on StockProof |
| Alkem Laboratories Limited INE540L01014 | Pharmaceuticals & Biotechnology | 2.09% | on StockProof |
| Glenmark Pharmaceuticals Limited INE935A01035 | Pharmaceuticals & Biotechnology | 2.07% | on StockProof |
| Biocon Limited INE376G01013 | Pharmaceuticals & Biotechnology | 1.88% | on StockProof |
| Zydus Lifesciences Limited INE010B01027 | Pharmaceuticals & Biotechnology | 1.76% | on StockProof |
| Mankind Pharma Limited INE634S01028 | Pharmaceuticals & Biotechnology | 1.71% | on StockProof |
| IPCA Laboratories Limited INE571A01038 | Pharmaceuticals & Biotechnology | 1.51% | on StockProof |
| Aster DM Quality Care Limited INE914M01019 | Healthcare Services | 1.35% | on StockProof |
| Krishna Institute Of Medical Sciences Limited INE967H01025 | Healthcare Services | 1.24% | on StockProof |
| Gland Pharma Limited INE068V01023 | Pharmaceuticals & Biotechnology | 1.23% | on StockProof |
| Sai Life Sciences Limited INE570L01029 | Pharmaceuticals & Biotechnology | 1.11% | on StockProof |
| Neuland Laboratories Limited INE794A01010 | Pharmaceuticals & Biotechnology | 1.01% | on StockProof |
| Wockhardt Limited INE049B01025 | Pharmaceuticals & Biotechnology | 1.01% | on StockProof |
| Acutaas Chemicals Limited INE00FF01025 | Pharmaceuticals & Biotechnology | 0.99% | on StockProof |
| Ajanta Pharma Limited INE031B01049 | Pharmaceuticals & Biotechnology | 0.91% | on StockProof |
| Dr. Lal Path Labs Limited INE600L01024 | Healthcare Services | 0.91% | on StockProof |
| Abbott India Limited INE358A01014 | Pharmaceuticals & Biotechnology | 0.88% | outside tracked universe |
| Narayana Hrudayalaya Limited INE410P01011 | Healthcare Services | 0.87% | on StockProof |
| Onesource Specialty Pharma Limited INE013P01021 | Pharmaceuticals & Biotechnology | 0.78% | on StockProof |
| Piramal Pharma Limited INE0DK501011 | Pharmaceuticals & Biotechnology | 0.76% | on StockProof |
| Global Health Limited INE474Q01031 | Healthcare Services | 0.75% | on StockProof |
| Granules India Limited INE101D01020 | Pharmaceuticals & Biotechnology | 0.73% | on StockProof |
| Anthem Biosciences Limited INE0CZ201020 | Pharmaceuticals & Biotechnology | 0.70% | on StockProof |
| GlaxoSmithKline Pharmaceuticals Limited INE159A01016 | Pharmaceuticals & Biotechnology | 0.67% | on StockProof |
| Natco Pharma Limited INE987B01026 | Pharmaceuticals & Biotechnology | 0.52% | on StockProof |
| Eris LifeSciences Limited INE406M01024 | Pharmaceuticals & Biotechnology | 0.51% | on StockProof |
| Rainbow Childrens Medicare Limited INE961O01016 | Healthcare Services | 0.48% | on StockProof |
| Jubilant Pharmova Limited INE700A01033 | Pharmaceuticals & Biotechnology | 0.46% | on StockProof |
| Pfizer Limited INE182A01018 | Pharmaceuticals & Biotechnology | 0.45% | on StockProof |
| Shilpa Medicare Limited INE790G01031 | Pharmaceuticals & Biotechnology | 0.45% | outside tracked universe |
| Syngene International Limited INE398R01022 | Healthcare Services | 0.45% | on StockProof |
| Cohance Lifesciences Limited INE03QK01018 | Pharmaceuticals & Biotechnology | 0.42% | on StockProof |
| Strides Pharma Science Limited INE939A01011 | Pharmaceuticals & Biotechnology | 0.42% | outside tracked universe |
| Emcure Pharmaceuticals Ltd INE168P01015 | Pharmaceuticals & Biotechnology | 0.41% | on StockProof |
| Poly Medicure Limited INE205C01021 | Healthcare Equipment & Supplies | 0.40% | on StockProof |
| Vijaya Diagnostic Centre Limited INE043W01024 | Healthcare Services | 0.40% | on StockProof |
| Jupiter Life Line Hospitals Limited INE682M01020 | Healthcare Services | 0.38% | outside tracked universe |
| Metropolis Healthcare Limited INE112L01020 | Healthcare Services | 0.38% | outside tracked universe |
| Marksans Pharma Limited INE750C01026 | Pharmaceuticals & Biotechnology | 0.34% | outside tracked universe |
| Indegene Limited INE065X01017 | Healthcare Services | 0.33% | on StockProof |
| Procter & Gamble Health Limited INE199A01012 | Pharmaceuticals & Biotechnology | 0.33% | outside tracked universe |
| AstraZeneca Pharma India Limited INE203A01020 | Pharmaceuticals & Biotechnology | 0.31% | outside tracked universe |
| Caplin Point Laboratories Limited INE475E01026 | Pharmaceuticals & Biotechnology | 0.31% | on StockProof |
| Concord Biotech Limited INE338H01029 | Pharmaceuticals & Biotechnology | 0.29% | on StockProof |
| Rubicon Research Limited INE506V01022 | Pharmaceuticals & Biotechnology | 0.29% | outside tracked universe |
| Alembic Pharmaceuticals Limited INE901L01018 | Pharmaceuticals & Biotechnology | 0.27% | outside tracked universe |
| Viyash Scientific Limited INE807F01027 | Pharmaceuticals & Biotechnology | 0.24% | outside tracked universe |
| Dr Agarwals Health Care Limited INE943P01029 | Healthcare Services | 0.23% | outside tracked universe |
| Alivus Life Sciences Limited INE03Q201024 | Pharmaceuticals & Biotechnology | 0.22% | outside tracked universe |
| Healthcare Global Enterprises Limited INE075I01017 | Healthcare Services | 0.22% | outside tracked universe |
| Thyrocare Technologies Limited INE594H01019 | Healthcare Services | 0.22% | outside tracked universe |
| Yatharth Hospital And Trauma Care Services Limited INE0JO301016 | Healthcare Services | 0.22% | outside tracked universe |
| Aarti Pharmalabs Limited INE0LRU01027 | Pharmaceuticals & Biotechnology | 0.21% | outside tracked universe |
| Senores Pharmaceuticals Limited INE0RB801010 | Pharmaceuticals & Biotechnology | 0.20% | outside tracked universe |
| Bliss GVS Pharma Limited INE416D01022 | Pharmaceuticals & Biotechnology | 0.19% | outside tracked universe |
| Sanofi Consumer Healthcare India Limited INE0UOS01011 | Pharmaceuticals & Biotechnology | 0.19% | outside tracked universe |
| Sanofi India Limited INE058A01010 | Pharmaceuticals & Biotechnology | 0.18% | outside tracked universe |
| Kovai Medical Center and Hospital Limited INE177F01017 | Healthcare Services | 0.17% | outside tracked universe |
| Akums Drugs and Pharmaceuticals Limited INE09XN01023 | Pharmaceuticals & Biotechnology | 0.14% | outside tracked universe |
| Supriya Lifescience Limited INE07RO01027 | Pharmaceuticals & Biotechnology | 0.14% | outside tracked universe |
| Suven Life Sciences Limited INE495B01038 | Healthcare Services | 0.14% | outside tracked universe |
| Blue Jet Healthcare Ltd INE0KBH01020 | Pharmaceuticals & Biotechnology | 0.13% | on StockProof |
| FDC Limited INE258B01022 | Pharmaceuticals & Biotechnology | 0.12% | outside tracked universe |
| Morepen Laboratories Limited INE083A01026 | Pharmaceuticals & Biotechnology | 0.12% | outside tracked universe |
| Sun Pharma Advanced Research Company Limited INE232I01014 | Pharmaceuticals & Biotechnology | 0.12% | outside tracked universe |
| Indraprastha Medical Corporation Limited INE681B01017 | Healthcare Services | 0.10% | outside tracked universe |
| Innova Captab Limited INE0DUT01020 | Pharmaceuticals & Biotechnology | 0.10% | outside tracked universe |
| IOL Chemicals and Pharmaceuticals Limited INE485C01029 | Pharmaceuticals & Biotechnology | 0.10% | outside tracked universe |
| Park Medi World Limited INE119201023 | Healthcare Services | 0.10% | outside tracked universe |
| Aarti Drugs Limited INE767A01016 | Pharmaceuticals & Biotechnology | 0.09% | outside tracked universe |
| Advanced Enzyme Technologies Limited INE837H01020 | Pharmaceuticals & Biotechnology | 0.09% | outside tracked universe |
| Artemis Medicare Services Limited INE025R01021 | Healthcare Services | 0.09% | outside tracked universe |
| Nephrocare Health Services Ltd INE428V01029 | Healthcare Services | 0.09% | outside tracked universe |
| Orchid Pharma Limited INE191A01027 | Pharmaceuticals & Biotechnology | 0.09% | outside tracked universe |
| Corona Remedies Limited INE02ZQ01018 | Pharmaceuticals & Biotechnology | 0.08% | outside tracked universe |
| Dishman Carbogen Amcis Limited INE385W01011 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Gufic Biosciences Limited INE742B01025 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Gujarat Themis Biosyn Ltd INE942C01045 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Kwality Pharmaceuticals Limited INE552U01010 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Novartis India Limited INE234A01025 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| RPG Life Sciences Limited INE105J01010 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| SMS Pharmaceuticals Limited INE812G01025 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Solara Active Pharma Sciences Limited INE624Z01016 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Unichem Laboratories Limited INE351A01035 | Pharmaceuticals & Biotechnology | 0.07% | outside tracked universe |
| Fischer Medical Ventures Limited INE771F01041 | Healthcare Equipment & Supplies | 0.06% | outside tracked universe |
| Hester Biosciences Limited INE782E01017 | Pharmaceuticals & Biotechnology | 0.06% | outside tracked universe |
| Krsnaa Diagnostics Limited INE08LI01020 | Healthcare Services | 0.06% | outside tracked universe |
| Vimta Labs Limited INE579C01029 | Healthcare Services | 0.06% | outside tracked universe |
| Hikal Limited INE475B01022 | Pharmaceuticals & Biotechnology | 0.05% | outside tracked universe |
| Indoco Remedies Limited INE873D01024 | Pharmaceuticals & Biotechnology | 0.05% | outside tracked universe |
| 3B BlackBio Dx Limited INE994E01018 | Healthcare Services | 0.04% | outside tracked universe |
| Dr.Agarwals Eye Hospital Limited INE934C01018 | Healthcare Services | 0.04% | outside tracked universe |
| Panacea Biotec Limited INE922B01023 | Pharmaceuticals & Biotechnology | 0.04% | outside tracked universe |
| Sigachi Industries Limited INE0D0K01022 | Pharmaceuticals & Biotechnology | 0.04% | outside tracked universe |
| Syncom Formulations India Limited INE312C01025 | Pharmaceuticals & Biotechnology | 0.04% | outside tracked universe |
| Wanbury Limited INE107F01022 | Pharmaceuticals & Biotechnology | 0.04% | outside tracked universe |
| Windlas Biotech Limited INE0H5O01029 | Pharmaceuticals & Biotechnology | 0.04% | outside tracked universe |
| Bajaj Healthcare Limited INE411U01027 | Pharmaceuticals & Biotechnology | 0.03% | outside tracked universe |
| Fermenta Biotech Limited INE225B01021 | Pharmaceuticals & Biotechnology | 0.03% | outside tracked universe |
| GPT Healthcare Limited INE486R01017 | Healthcare Services | 0.03% | outside tracked universe |
| Jagsonpal Pharmaceuticals Limited INE048B01035 | Pharmaceuticals & Biotechnology | 0.03% | outside tracked universe |
| KMC Speciality Hospitals (India) Limited INE879K01018 | Healthcare Services | 0.03% | outside tracked universe |
| Kopran Limited INE082A01010 | Pharmaceuticals & Biotechnology | 0.03% | outside tracked universe |
| Lincoln Pharmaceuticals Limited INE405C01035 | Pharmaceuticals & Biotechnology | 0.03% | outside tracked universe |
| Shalby Limited INE597J01018 | Healthcare Services | 0.03% | outside tracked universe |
| Suraksha Diagnostic Limited INE877V01027 | Healthcare Services | 0.03% | outside tracked universe |
| Tarsons Products Limited INE144Z01023 | Healthcare Equipment & Supplies | 0.03% | outside tracked universe |
| Gujarat Kidney And Super Speciality Limited INE0V0W01025 | Healthcare Services | 0.02% | outside tracked universe |
| Laxmi Dental Limited INE0WO601020 | Healthcare Equipment & Supplies | 0.02% | outside tracked universe |
| Themis Medicare Ltd INE083B01024 | Pharmaceuticals & Biotechnology | 0.02% | outside tracked universe |
| Anuh Pharma Ltd INE489G01022 | Pharmaceuticals & Biotechnology | 0.01% | outside tracked universe |
| Fabtech Technologies Limited INE0HF201011 | Healthcare Equipment & Supplies | 0.01% | outside tracked universe |
| Health X Platform Limited INE019J01013 | Healthcare Services | 0.01% | outside tracked universe |
| Nectar Lifesciences Limited INE023H01027 | Pharmaceuticals & Biotechnology | 0.01% | outside tracked universe |
| Shree Ganesh Remedies Limited INE414Y01015 | Pharmaceuticals & Biotechnology | 0.01% | outside tracked universe |
Every line the fund house disclosed is listed above, in the order it weighs. Weights are the fund house's own "% to NAV" figures, normalised to a percentage of the whole fund; they are not rescaled to add to 100%.
NAV history
NAV as published by AMFI for each date. No corporate-action adjustment is applied or needed — an IDCW payout is carried by a separate scheme code, not by restating this series.
Returns (CAGR)
Compound annual growth of NAV over each trailing window, computed from stored history with the same function the company pages use. A window is only shown as a number when the stored history genuinely reaches back that far — it is never computed over a shorter span and labelled as the longer one.
| Window | CAGR | Basis |
|---|---|---|
| 1-year | 18.46% | NAV 44.2169 on 28 Aug 2025 to 52.3744 on 28 Aug 2026 (1-year, AMFI) |
| 3-year | 23.44% | NAV 27.9083 on 01 Sep 2023 to 52.3744 on 28 Aug 2026 (3-year, AMFI) |
| 5-year | N/A | Stored NAV history starts 01 Sep 2023, which does not reach back a full 5 years from 28 Aug 2026. |
| 10-year | N/A | Stored NAV history starts 01 Sep 2023, which does not reach back a full 10 years from 28 Aug 2026. |
| Since stored history begins | 23.44% | NAV 27.9083 on 01 Sep 2023 to 52.3744 on 28 Aug 2026 (3.0 years stored, AMFI) |
"Since stored history begins" is deliberately not called "since inception" — AMFI publishes no NAV before 1 April 2006, so for an older fund its true inception NAV is not in any public AMFI feed.